Yu J, Lv YM, Yang P, Jiang YZ, Qin XR, Wang XY. Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection. World J Gastroenterol 2023; 29(20): 3133-3144 [PMID: 37346155 DOI: 10.3748/wjg.v29.i20.3133]
Corresponding Author of This Article
Xiao-Yong Wang, MD, Assistant Professor, Chief Physician, Postdoc, Department of Gastroenterology, The Affiliated Changzhou No. 2 People’s Hospital of Nanjing Medical University, No. 29 Xinglong Lane, Tianning District, Changzhou 213000, Jiangsu Province, China. wxy20009@126.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Clinical Trials Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Table 4 Comparison of liver and kidney function before and after treatment
Characteristic
Before (n = 41)
After (n = 41)
P value
Total bilirubin (μmol/L), mean ± SD
13.68 ± 4.82
14.96 ± 5.22
0.252
ALT (U/L), mean ± SD
16.92 ± 8.33
21.46 ± 16.03
0.270
AST (U/L), mean ± SD
18.99 ± 7.61
21.03 ± 10.67
0.670
Creatinine (μmol/L), mean ± SD
60.105 ± 12.060
60.53 ± 11.35
0.974
Citation: Yu J, Lv YM, Yang P, Jiang YZ, Qin XR, Wang XY. Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection. World J Gastroenterol 2023; 29(20): 3133-3144